RDNT Stock Analysis: Buy, Sell, or Hold?
RDNT - RadNet, Inc. Common Stock
$53.43
0.45 (0.85%)
▲
5d:
-7.08%
30d:
-8.23%
90d:
-18.1%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
RDNT is down 7.1% this week, but smart money is accumulating calls. Top strike: $80 2026-06-18 with 176 OI. Call ratio: 75% View Scanner →
Strength: 6.1/10
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$53.55
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$33.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $53.43, which is considered slightly low relative to its 30-day fair value range of $55.83 to $58.65. From a valuation perspective, the stock is trading at a discount (Forward PE: 48.6) compared to its historical average (77.3). Remarkably, the market is currently pricing in an annual earnings decline of 14.3% over the next few years. This pessimistic expectation contrasts with the company's recent 75.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RDNT is in a strong downtrend. Immediate support is located at $51.68, while resistance sits at $63.45.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.38 (+69.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RDNT is in a strong downtrend. Immediate support is located at $51.68, while resistance sits at $63.45.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.38 (+69.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$55.83 -
$58.65
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.1% below Wall St target ($90.38)
- CAUTION: 5-day price weakness (-7.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$55.83 -
$58.65
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$51.68
Resistance Level
$63.45
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
48.57
Wall Street Target
$90.38
(+69.1%)
Revenue Growth (YoY)
22.1%
Earnings Growth (YoY)
75.0%
Profit Margin
-0.7%
Valuation Discount vs History
-14.3% cheaper
PE vs Historical
48.6 vs 77.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.3%
(market-implied from PE analysis)
1-Year Target
$48.09
(-10%)
2-Year Target
$43.28
(-19%)
3-Year Target
$38.95
(-27%)
3-Yr Target (if PE normalizes)
(PE: 49→77)
$61.99
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 48.6, Growth: 92.3%)
$180.33
(+238%)
Base:
(SPY PE: 22.0, Growth: 92.3%)
$81.82
(+53%)
Bear:
(PE: 18.7, Growth: 92.3%)
$69.55
(+30%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 48.6 to 77.3
Stabilization Target:
$85.03
(+59.1%)
PE Expansion Potential:
+59.1%
Share & Embed Analysis
Last updated: May 15, 2026 3:43 AM ET
Data refreshes hourly during market hours. Next update: 4:43 AM
Data refreshes hourly during market hours. Next update: 4:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Alma Gregory Sorensen
SELL
15000 shares
2026-03-18
Mital Patel
SELL
15080 shares
2025-11-19
Mital Patel
SELL
9920 shares
2025-11-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 58 HOLD |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
